Cargando…

The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide

Cell-penetrating peptides (CPPs), which can facilitate the transport of molecular cargo across the plasma membrane, have become important tools in promoting the cellular delivery of macromolecules. GV1001, a peptide derived from a reverse-transcriptase subunit of telomerase (hTERT) and developed as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hong, Seo, Eun-Hye, Lee, Seung-Hyun, Kim, Bum-Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187854/ https://www.ncbi.nlm.nih.gov/pubmed/27941629 http://dx.doi.org/10.3390/ijms17122054

Ejemplares similares

A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways
por: Kim, Jae Hyeon, et al.
Publicado: (2022)

A phase II study of chemotherapy in combination with telomerase peptide vaccine (GV1001) as second-line treatment in patients with metastatic colorectal cancer
por: Kim, Sejin, et al.
Publicado: (2022)

Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice
por: Kim, Shin Hye, et al.
Publicado: (2018)

Protective effects of GV1001 on myocardial ischemia-reperfusion injury
por: Chang, Ji-Eun, et al.
Publicado: (2017)

Outcomes of Peptide Vaccine GV1001 Treatment in a Murine Model of Acute Noise-Induced Hearing Loss
por: Lee, Sang-Yeon, et al.
Publicado: (2020)

hTERT peptide fragment GV1001 demonstrates radioprotective and antifibrotic effects through suppression of TGF-β signaling
por: Chen, Wei, et al.
Publicado: (2018)

The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma
por: Park, Joo Kyung, et al.
Publicado: (2016)

GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice
por: Kim, Sharon Y., et al.
Publicado: (2023)

The Anti-inflammatory Effect of GV1001 Mediated by the Downregulation of ENO1-induced Pro-inflammatory Cytokine Production
por: Choi, Jiyea, et al.
Publicado: (2015)

Neuroprotective Effects of GV1001 in Animal Stroke Model and Neural Cells Subject to Oxygen-Glucose Deprivation/Reperfusion Injury
por: Kwon, Hyuk Sung, et al.
Publicado: (2021)

Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
por: Inderberg-Suso, Else-Marit, et al.
Publicado: (2012)

Effects of GV1001 on Language Dysfunction in Patients With Moderate-to-Severe Alzheimer’s Disease: Post Hoc Analysis of Severe Impairment Battery Subscales
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition
por: Kim, Yejin, et al.
Publicado: (2021)

GV1001 inhibits cell viability and induces apoptosis in castration-resistant prostate cancer cells through the AKT/NF-κB/VEGF pathway
por: Park, Yong Hyun, et al.
Publicado: (2019)

Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner
por: Kim, Hong, et al.
Publicado: (2016)

Enhanced delivery of protein fused to cell penetrating peptides to mammalian cells
por: Moon, Jung-Il, et al.
Publicado: (2019)

Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
por: Habault, Justine, et al.
Publicado: (2019)

Characterization of a Cell‐Penetrating Peptide with Potential Anticancer Activity
por: Gronewold, Anja, et al.
Publicado: (2016)

Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
por: Dosset, Magalie, et al.
Publicado: (2013)

Anti-metastatic effect of GV1001 on prostate cancer cells; roles of GnRHR-mediated Gαs-cAMP pathway and AR-YAP1 axis
por: Kim, Ji Won, et al.
Publicado: (2021)

The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
por: Kim, Yelee, et al.
Publicado: (2022)

Designing Potent Anticancer Peptides by Aurein 1.2 Key Residues Mutation and Catenate Cell-Penetrating Peptide
por: Salarpour Garnaie, Hamta, et al.
Publicado: (2023)

The J-Domain of Heat Shock Protein 40 Can Enhance the Transduction Efficiency of Arginine-Rich Cell-Penetrating Peptides
por: Lin, Tzu-Yin, et al.
Publicado: (2015)

Cell-penetrating peptide-conjugated copper complexes for redox-mediated anticancer therapy
por: Peña, Quim, et al.
Publicado: (2022)

Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial
por: Koh, Seong-Ho, et al.
Publicado: (2021)

Tumor-Penetrating Peptides
por: Teesalu, Tambet, et al.
Publicado: (2013)

A Telomerase-Derived Peptide Exerts an Anti-Hepatitis B Virus Effect via Mitochondrial DNA Stress-Dependent Type I Interferon Production
por: Choi, Yu-Min, et al.
Publicado: (2020)

Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022)

Anticancer Activity of Periplanetasin-5, an Antimicrobial Peptide from the Cockroach Periplaneta americana
por: Kim, In-Woo, et al.
Publicado: (2021)

1001 noches.
Publicado: (1945)

MONO 1001
por: Pacquet, J Y, et al.
Publicado: (2002)

Accumulation of T-cell-suppressive PD-L1(high) extracellular vesicles is associated with GvHD and might impact GvL efficacy
por: Baur, Rebecca, et al.
Publicado: (2023)

Cell-Penetrating Peptides and Transportan
por: Langel, Ülo
Publicado: (2021)

Peptides with Dual Antimicrobial–Anticancer Activity: Strategies to Overcome Peptide Limitations and Rational Design of Anticancer Peptides
por: Liscano, Yamil, et al.
Publicado: (2020)

Disruptin, a cell-penetrating peptide degrader of EGFR: Cell-Penetrating Peptide in Cancer Therapy
por: Mehta, Ranjit K., et al.
Publicado: (2021)

Cellular Reprogramming Using Protein and Cell-Penetrating Peptides
por: Seo, Bong Jong, et al.
Publicado: (2017)

Heat Shock Protein–Peptide and HSP-Based Immunotherapies for the Treatment of Cancer
por: Shevtsov, Maxim, et al.
Publicado: (2016)

Anatomical features of the GV20 acupoint
por: Kim, Sang Hyun, et al.
Publicado: (2023)

Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability
por: Hu, Cuihua, et al.
Publicado: (2018)

Polypharmacological Cell-Penetrating Peptides from Venomous Marine Animals Based on Immunomodulating, Antimicrobial, and Anticancer Properties
por: Hemmati, Shiva, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_89h6v3fiuovg0p50lf9isof2kq